Home›Companies›Biotech & Pharma›Exxel Pharma

Exxel Pharma, INC.

Updated Oct 29, 2026·Latest SEC filing Dec 2, 2024·Suggest an edit

About Exxel Pharma

Exxel Pharma is a private company based in Aurora, Colorado. It has reported $600,000 raised in one offering on Form D since December 2024. Its chief executive is Soren Mogelsvang.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 20, 2024Dec 2, 2024$600,000fully sold1$600KDebtRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Exxel Pharma's Form D filed Dec 2, 2024.

SM
Soren Mogelsvang
CEO and director
GY
Guy Yachin
Director

Sources

  1. SECExxel Pharma, INC. filing history